STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $7,267,000 | -16.8% | 495,384 | +15.5% | 0.01% | -12.5% |
| Q1 2014 | $8,736,000 | +17.4% | 429,078 | +13.0% | 0.01% | +14.3% |
| Q4 2013 | $7,443,000 | -58.6% | 379,741 | -4.3% | 0.01% | -61.1% |
| Q3 2013 | $17,963,000 | +154.0% | 396,619 | +33.7% | 0.02% | +157.1% |
| Q2 2013 | $7,073,000 | – | 296,693 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,241,293 | $18,992,000 | 6.12% |
| Consonance Capital Management LP | 2,606,598 | $39,881,000 | 3.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,517,000 | 2.93% |
| NEXTHERA CAPITAL LP | 523,624 | $8,011,000 | 1.32% |
| Eventide Asset Management | 1,086,400 | $16,622,000 | 0.78% |
| Virtus ETF Advisers LLC | 51,678 | $791,000 | 0.69% |
| KNOTT DAVID M | 90,000 | $1,377,000 | 0.57% |
| Avoro Capital Advisors LLC | 524,321 | $8,022,000 | 0.38% |
| Telemetry Investments, L.L.C. | 18,500 | $283,000 | 0.11% |
| Artal Group S.A. | 400,000 | $6,120,000 | 0.08% |